한국어
Quantus

Immatics

IMTX · Nasdaq
$9.56+1.06%
2026-09-04 close

Immatics last closed at $9.56 (+1.06%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

B
Overall: 건강관리 329/745 · top 44%
Factor composite · relative position in sector

PER 504.38 · PBR 9.06 — own-history percentile 22/100 · 9/100

Open self-history band
PER22/100
PBR9/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2019
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 29.92
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
29.92
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
1.95%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROAPass
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 342% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Connections

AI-extracted related companies · for reference

Customers
Bristol Myers SquibbPrice comovement r=0.31 (1 year)Takeda PharmaceuticalAstraZenecaGenmab
Same theme
CAR-T 세포치료
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Immatics
What technical signals does Immatics (IMTX) have?
Immatics current technical signals: no active technical signal.
Is Immatics a cup-and-handle pattern?
No. Immatics has no valid cup-and-handle signal right now.
What are Immatics's financials and valuation?
Immatics's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy